Ground Fluor Pharmaceuticals

company

About

Ground Fluor Pharmaceuticals develops new imaging agents for use in diagnosis and management of disease, and to help other companies.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$180K
Industries
Pharmaceutical,Therapeutics
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Ground Fluor Pharmaceuticals developed new chemistry technology which transforms complicated and costly fluorine syntheses into simpler, more efficient processes. Using technology developed at the University of Nebraska and the Massachusetts General Hospital and funded by the National Science Foundation and Cedarville Investments, Ltd., GFP has developed and patented processes and intermediate chemicals for the efficient, cost-effective production of PET imaging agents.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.52M
Ground Fluor Pharmaceuticals has raised a total of $1.52M in funding over 2 rounds. Their latest funding was raised on Apr 3, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 3, 2014 Grant $1.34M 1 National Science Foundation Detail
Jun 14, 2012 Grant $180K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Ground Fluor Pharmaceuticals is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant